Skip to main content
. 2020 Apr 27;122(12):1744–1746. doi: 10.1038/s41416-020-0838-2

Fig. 1. Results as proportions of low and high-risk predictions.

Fig. 1

Top row displays whole cohort (n = 94) Left: Stratified according to clinical criteria of the MINDACT study (Cardoso et al., NEJM 2016), middle: with EndoPredict, right: with MammaPrint. Bottom row displays clinically high-risk cases. Left: Clinically high-risk cases (n = 43) further stratified with EndoPredict (middle) and MammaPrint (right).